Pharmacokinetics of bumetanide in critically ill infants

Clinical Pharmacology and Therapeutics

Volumn 60, Issue 4, 1996, Pages 405-413

  Sullivan, Janice E ^b   Witte, Madolin K ^c   Yamashita, Toyoko S ^d   Myers, Carolyn M ^d   Blumer, Jeffrey L ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

^b University of Louisville School of Medicine   (United States)

^c UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUMETANIDE;

AGE; AREA UNDER THE CURVE; ARTICLE; CRITICAL ILLNESS; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG EXCRETION; DRUG HALF LIFE; DRUG METABOLISM; DRUG URINE LEVEL; FEMALE; HUMAN; INFANT; INTRAVENOUS DRUG ADMINISTRATION; KIDNEY CLEARANCE; MAJOR CLINICAL STUDY; MALE; MEAN RESIDENCE TIME; NEWBORN; PHARMACOKINETICS; PRIORITY JOURNAL; STEADY STATE;

AREA UNDER CURVE; BUMETANIDE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRITICAL ILLNESS; DIURETICS; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; INJECTIONS, INTRAVENOUS; MALE; PROSPECTIVE STUDIES;

EID: 0029856835     PISSN: 00099236     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9236(96)90197-6     Document Type: Article

References (32)

1. Baliga R, Lewy JE. Pathogenesis and treatment of edema. Pediatr Clin North Am 1987;34:639-48.
2. Witte MK, Stork JE, Blumer JL. Diuretic therapeutics in the pediatric patient. Am J Cardiol 1986;57:44A-53A.
3. Wells TG. The pharmacology and therapeutics of diuretics in the pediatric patient. Pediatr Clin North Am 1990;37:463-503.
4. Tuzel IH. Comparison of adverse reactions to bumetanide and furosemide. J Clin Pharmacol 1981;21: 615-9.
5. Ramsay LE, McInnes GT, Hettiarachchi J, Shelton J, Scott P. Bumetanide and furosemide: a comparison of dose-response curves in healthy men. Br J Clin Pharmacol 1978;5:243-7.
6. Asbury MJ, Gatenby PBB, O'Sullivan S, Bourke E. Bumetanide: potent new "loop" diuretic. Br Med J 1972;1:211-3.
7. Aranda JV, Turmen T, Sasyniuk BI. Pharmacokinetics of diuretics and methylxanthines in the neonate. Eur J Clin Pharmacol 1980;18:55-63.
8. Turmen T, Thom P, Louridas, AT, LeMorvan P, Aranda JV. Protein binding and bilirubin displacing properties of bumetanide and furosemide. J Clin Pharmacol 1982;22:551-6.
9. Robertson A, Karp W. Albumin binding of bumetanide. Dev Pharmacol Ther 1986;9:241-8.
10. Bourke E. Frusemide, bumetanide, and ototoxicity. Lancet 1976;1:917-8.
11. Brown RD, Manno JE, Daigneault EA, Manno BR. Comparative acute ototoxicity of intravenous bumetanide and furosemide in the pure-bred beagle. Toxicol Appl Pharmacol 1979;48:157-69.
12. Dunn FG, Kerr IC, McQueen MJ, Thomson RM. Comparison of intravenous bumetanide and frusemide during open heart surgery. Postgrad Med 1975;51(suppl 6):72-6.
13. Wells TG, Fasules JW, Taylor BJ, Kearns GL. Pharmacokinetics and pharmacodynamics of bumetanide in neonates treated with extracorporeal membrane oxygenation. J Pediatr 1992;121:974-80.
14. Shankaran S, Ilaqan N, Liang KC, Bhavsar V, Kauffman R. Bumetanide pharmacokinetics in preterm neonates [abstract]. Pediatr Res 1989;25:72A.
15. Lopez AM, Modi MW, Adams JA, Horner GP, De-Grazia FT, Goldberg RN. Pharmacokinetics of bumetanide in the newborn infant [abstract]. Pediatr Res 1990;27:62A.
16. Goldman L, Hashimoto B, Cook EF, Loscalzo A. Comparative reproducibility and validity of systems for assessing cardiovascular functional class: advantages of a new specific activity scale. Circulation 1981; 64:1227-34.
17. Papadopoulou ZL, Tina LU, Sandler P, Jose PA, Calcagno PL. Size and function of the kidneys. In: Johnson TR, Moore WM, Jeffries JE, editors. Children are different. Columbus: Ross Laboratories, 1978:98-103.
18. Schwartz GJ, Brion LP, Spitzer A. The use of plasma creatinine concentration for estimating glomerular filtration rate in infants, children and adolescents. Pediatr Clin North Am 1987;34:571-90.
19. Gibaldi M, Perrier D. Noncompartmental analysis based on statistical moment theory. In: Gibaldi M, Perrier D, editors. Pharmacokinetics. New York: Marcel Dekker, 1982:409-18.
20. Borenstein M, Cohen J. Statistical power analysis: a computer program. Hillsdale, NJ: Lawence Erlbaum Associates Inc, 1988.
21. Lau HS, Hyneck ML, Berardi RR, Swartz RD, Smith DE. Kinetics, dynamics, and bioavailability of bumetanide in healthy subjects and patients with chronic renal failure. Clin Pharmacol Ther 1986;39:635-45.
22. Halladay SC, Sipes IG, Carter DE. Diuretic effect and metabolism of bumetanide in man. Clin Pharmacol Ther 1977;22:179-87.
23. Holazo AA, Colburn WA, Gustafson JH, Young RL, Parsonnet M. Pharmacokinetics of bumetanide following intravenous, intramuscular and oral administrations to normal subjects. J Pharm Sci 1984;73:1108-13.
24. Cook JA, Smith DE, Cornish LA, Tankanow RM, Nicklas JM, Hyneck ML. Kinetics, dynamics and bioavailability of bumetanide in healthy subjects and patients with congestive heart failure. Clin Pharmacol Ther 1988;44:487-500.
25. Benet LZ, Williams RL. Design and optimization of dosage regimens: pharmacokinetic data. In: Gilman AG, Rall TW, Nies AS, Taylor P, editors. The pharmacologic basis of therapeutics. New York: Pergamon Press, 1990:1650-735.
26. Walker PC, Berry NS, Edwards DJ. Protein binding characteristics of bumetanide. Dev Pharmacol Ther 1989;12:13-8.
27. Blumer JL, Reed MD. Principles of neonatal pharmacology. In: Yaffe SJ, Aranda JV, editors. Pediatric pharmacology. Philadelphia: WB Saunders, 1992:164-77.
28. Vert P, Broquaire M, Legagneur M, Morselli PL. Pharmacokinetics of furosemide in neonates. Eur J Clin Pharmacol 1982;22:39-45.
29. Peterson RG, Simmons MA, Rumack BH, Levine RL, Brooks JG. Pharmacology of furosemide in the premature newborn infant. J Pediatr 1980;97:139-43.
30. Aranda JV, Perez J, Sitar DS, Collinge J, Portuguez-Malavasi A, Duffy B, et al. Pharmacokinetic disposition and protein binding of furosemide in newborn infants. J Pediatr 1978;93:507-11.
31. Tuck S, Morselli P, Broquaire M, Vert P. Plasma and urinary kinetics of furosemide in newborn infants. J Pediatr 1983;103:481-5.
32. Ward OC, Lam LKT. Bumetanide in heart failure in infancy. Arch Dis Child 1977;52:877-82.